BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 4, 2007
View Archived Issues
Cytokinetics Forms $725M Heart Disease Alliance With Amgen
Providing leverage for a small-molecule program targeted at heart failure, Cytokinetics Inc. is collaborating with Amgen Inc. in a deal potentially worth $725 million. (BioWorld Today)
Read More
Genentech Paying Exelixis $40M In MEK Inhibitor Deal
Read More
Cloned Cows Safe, Knockouts Healthy, But Not In Supermarket
Read More
FivePrime Signs Discovery Deal With Centocor; $15M Up Front
Read More
VaxGen Future Unclear With Additional $51M Celltrion Sale
Read More
FDA Signs Off On Poniard's Phase III Picoplatin Protocol
Read More
Other News To Note
Read More
Clinic Roundup
Read More